Fig. 5From: Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemiaa RFS in AML patients receiving complete consolidation therapy with IDAC regimen classify by type of gene mutation. b OS in AML patients receiving complete consolidation therapy with IDAC regimen classify by type of gene mutationBack to article page